In this regard, the initial studies on ITH in GBM revealed the coactivation of multiple RTKs, including EGFR, MET, and PDGFR, necessitating a poly-targeting approach to disrupt downstream signaling pathways [25,26]. This evidence concerns the gene MET and glioblastoma.